Skip to content

NeoVolta NEOV Deferred Tax Assets, Valuation Allowance

Deferred Tax Assets, Valuation Allowance at other companies

Cineverse Corp. logo
Cineverse Corp.CNVS
$31.36M+0.7%
Envoy Medical logo
Envoy MedicalCOCH
$654K+2.5%
State Street logo
State StreetSTT
$198M+15.1%
OFG Bancorp logo
OFG BancorpOFG
$568K-87.9%
BK
BKBK
$127M-5.9%
PepsiCo logo
PepsiCoPEP
$6.12B-1.1%

Other financials

Income statement

See full
Revenue$2.0M+0.5%
Gross profit$927.8K+80.3%
Operating income-$2.6M-91.5%
Net income-$3.0M-109%
EPS (diluted)-$0.08-100%

Balance sheet

See full
Cash & equivalents$11.5M+2,042%
Total debt$1.5M+2.2%
Total equity$22.2M+480%
Total assets$25.7M+349%

Cash flow

See full
Operating cash flow-$3.6M-74.6%

Valuation

See full
Market cap$172.96M+43.6%
Enterprise value$162.93M+33.1%
P/S9.6×-4.7×

Profitability

See full
Gross margin21.3%-1.0pp
Operating margin-52%-16.1pp
Net margin-63.4%-16.2pp

Returns & leverage

See full
Return on equity-88.1%-3.4pp
Debt / equity0.1×-0.3×
Current ratio8.1×+4.3×

Where this comes from

Reported directly by NeoVolta in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsValuationAllowance.

The official record: NeoVolta’s 10-K, filed September 29, 2025, on SEC EDGAR. View the filing →

Ask your AI about NeoVolta's deferred tax assets, valuation allowance.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NeoVolta's deferred tax assets, valuation allowance?
NeoVolta (NEOV) reported deferred tax assets, valuation allowance of $1.57M in Q2 2025.
What is the long-term trend for NeoVolta's deferred tax assets, valuation allowance?
Over 4 years (2021 to 2025), NeoVolta's deferred tax assets, valuation allowance has grown at a 50.0% compound annual growth rate (CAGR), from $310.2K to $1.57M.